Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk

Early percutaneous coronary intervention (PCI) and long-term aggressive antithrombotic treatment based on dual antiplatelet therapy (DAPT) are the most important elements in the treatment of patients with acute coronary syndrome (ACS). The most studied and recommended for ACS is the 12-month DAPT (c...

Ausführliche Beschreibung

Bibliografische Detailangaben

1. Verfasser:	O. V. Averkov
Format:	Artigo
Sprache:	Russo
Veröffentlicht:	«FIRMA «SILICEA» LLC 2021-02-01
Schriftenreihe:	Российский кардиологический журнал
Schlagworte:	acute coronary syndrome percutaneous coronary intervention dual antiplatelet therapy bleeding risk acetylsalicylic acid discontinuation clopidogrel ticagrelor prasugrel
Online-Zugang:	https://russjcardiol.elpub.ru/jour/article/view/4305
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!